InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Sr One Capital Management, Llc. Officer active across 4 companies, notably Arcellx, Inc.. Aggregated, 11 reports have been published. Split: 3 buys · 2 sells. Total volume traded: €35.6m. Activity tracked since 11 May 2023. The latest transaction was filed on 1 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sr One Capital Management, Llc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,419,298 sharesCommon StockSEC:0001193125-26-201887:0
489,486 sharesCommon StockSEC:0001193125-26-201887:1
277,778 shares@ US$18.000.40% mcap50.0% of flowCommon StockSEC:0001193125-26-201887:2
Canonical exit: 30 Jul 2026 (T+90)
354,824 sharesCommon StockSEC:0001193125-26-201887:3
489,486 sharesCommon StockSEC:0001193125-26-201887:4
277,777 shares@ US$18.000.40% mcap50.0% of flowCommon StockSEC:0001193125-26-201887:5
Canonical exit: 30 Jul 2026 (T+90)
63,158 shares@ US$19.00100.0% of flowCommon StockSEC:0001193125-25-239153:0
Canonical exit: 7 Jan 2026 (T+90)
1,505,388 sharesCommon StockSEC:0000950170-24-106978:0
430,578 shares@ €0.5544100.0% of flowCommon StockSEC:0001209191-23-056920:0
631,932 shares@ US$45.00100.0% of flowCommon StockSEC:0001209191-23-029610:0
1,550,309 sharesCommon StockSEC:0001209191-22-008281:0
11 of 11 declarations
About Sr One Capital Management, Llc
SR ONE CAPITAL MANAGEMENT, LLC is a declarant associated with Arcellx, Inc., Zenas BioPharma, Inc. and eFFECTOR Therapeutics, Inc. The record shows 5 filings in total. In the most recent sampled filings, from 2022-02-10 to 2024-09-16, the reported sell amount is EUR 26298596 and the reported buy amount is EUR 0.
